The turnover of Biotechnology Research and Experimental Development in Denmark has exhibited significant growth over the past decade. In 2023, the turnover stood at 781.8 Million Euros, indicating a robust industry trajectory. The year-on-year variations show significant fluctuations, with standout increases in 2016 (21.46%) and 2017 (20.77%). The last two years saw a growth of 4.81% in 2022 and 4.5% in 2023. The average annual growth rate (CAGR) over the past five years has been 4.85%, reflecting steady expansion. Future trends suggest continued growth albeit at a slightly moderated pace, with a forecasted five-year CAGR of 2.95% through 2028 and an overall forecasted five-year growth rate of 15.63%.
Future trends to watch for:
- Potential technological breakthroughs enhancing R&D capabilities.
- Changes in governmental funding and policies impacting the biotech sector.
- Global market dynamics and international collaborations.
